Correction: A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis

Zeming Liu; Wen Zeng; Tianwen Chen; Yawen Guo; Chao Zhang; Chunping Liu; Tao Huang

doi:10.18632/oncotarget.24998

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis

PDF | How to cite

Oncotarget. 2018; 9:16271-16271. https://doi.org/10.18632/oncotarget.24998

Metrics: PDF 1583 views | ?

Zeming Liu^1,*, Wen Zeng^2,*, Tianwen Chen¹, Yawen Guo¹, Chao Zhang³, Chunping Liu^1,* and Tao Huang^1,*

¹ Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
² Department of Ophthalmology, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, China
³ Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
^* These authors contributed equally to this work

Published: March 23, 2018

This article has been corrected: The proper name of the institution is as follows:

¹ Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Original article: Oncotarget. 2017; 8:6222-6232 DOI: https://doi.org/10.18632/oncotarget.14055.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24998

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis